DIO Corporation (KOSDAQ:039840)
8,280.00
-440.00 (-5.05%)
Nov 20, 2026, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 106.04 billion as of November 20, 2026. It is the 26,218th most valuable company in the world and the 1,148th biggest in South Korea. Its market cap has decreased by 52.00% in one year.
Market Cap
106.04B
Enterprise Value
143.50B
Revenue
174.45B
Global Rank
Country Rank
#1,148 South Korea
PE Ratio
5.41
ChartMarket Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 106.04B, an increase of 317.12%. That is a compound annual growth rate of 5.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 106.04B | -53.11% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.65T |
| Celltrion | 48.66T |
| ALTEOGEN | 12.14T |
| Samsung Epis Holdings | 8.67T |
| Kyongbo Pharmaceutical | 115.95B |
| SAMSUNG PHARM. Co., LTD. | 114.92B |
| AptaBio Therapeutics | 114.06B |
| Ilyang Pharmaceutical Co.,Ltd | 111.13B |